HUNTER SYNDROME
Clinical trials for HUNTER SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HUNTER SYNDROME trials appear
Sign up with your email to follow new studies for HUNTER SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early enzyme therapy may help kids with rare disease grow better
Disease control CompletedThis study followed 21 boys with Hunter syndrome who started taking Elaprase before age 6. Researchers tracked their height and weight for at least 5 years to see if the drug helps them grow more like other children. The study also monitored safety and compared growth data to unt…
Matched conditions: HUNTER SYNDROME
Phase: PHASE4 • Sponsor: Shire • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Hunterase extended trial shows promise for managing hunter syndrome
Disease control CompletedThis study looked at the long-term safety and effectiveness of Hunterase (idursulfase beta) in 30 people with Hunter syndrome over about one year. Participants had either completed a previous phase 3 study or had used Hunterase for at least six months. The goal was to monitor sid…
Matched conditions: HUNTER SYNDROME
Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC